ESC 365 - In vivo KCNH2-suppression-replacement gene therapy attenuates the pathogenic phenotype in transgenic rabbits with short QT syndrome type 1

EHRA Premium Access

In vivo KCNH2-suppression-replacement gene therapy attenuates the pathogenic phenotype in transgenic rabbits with short QT syndrome type 1

Session: Young Investigator Award Basic and Translational Science

Topic: Ion Channels, Electrophysiology

Speaker: Ms S. Nimani (Bern, CH)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Ms Saranda Nimani

University of Bern, Bern (Switzerland)

0 follower

4 more presentations in this session

Accelerated pacing reduces left heart filling pressures: a novel therapy for heart failure with preserved ejection fraction?

Speaker: Mr T. Van Loon (Maastricht, NL)

The right atrium affects in silico arrhythmia vulnerability in both atria

Speaker: Ms P. Martinez Diaz (Karlsruhe, DE)

Revealing intracavitary catheter positions: artificial intelligence-enhanced localization with an electrogram-driven variational autoencoder model

Speaker: Mr G. Rios-Munoz (Madrid, ES)

Reduced heart failure hospitalizations and improved quality of life in cardiac amyloidosis patients undergoing atrial fibrillation ablation

Speaker: Doctor N. Pierucci (Rome, IT)

Access the full session

Young Investigator Award Basic and Translational Science

Speakers: Ms S. Nimani, Mr T. Van Loon, Ms P. Martinez Diaz, Mr G. Rios-Munoz, Doctor N. Pierucci

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources